MTOR inhibitors
What are MTOR inhibitors?
Mammalian target of rapamycin (mTOR) inhibitors block the activity of the mammalian target of rapamycin. Mammalian target of rapamycin is a protein kinase, which regulates growth factors that stimulate cell growth and angiogenesis. In certain cancers the mTOR pathway is more active.
Mammalian target of rapamycin (mTOR) inhibitors are used in treatment of renal cancer and is being studied for use in other types of cancers. More benefits are being seen when MTOR inhibitors are combined with other chemotherapy agents.
List of MTOR inhibitors
View by Generic | Brand
| Drug Name | Avg. Rating | Reviews |
|---|---|---|
| Afinitor (Pro) Generic name: everolimus |
20 reviews | |
| Rapamune (Pro) Generic name: sirolimus |
3 reviews | |
| Torisel (Pro) Generic name: temsirolimus |
2 reviews | |
| Zortress (Pro) Generic name: everolimus |
1 review | |
| Hyftor (Pro) Generic name: sirolimus | No reviews | |
| Fyarro Generic name: sirolimus protein-bound | No reviews | |
| Afinitor Disperz Generic name: everolimus | No reviews | |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
See also
Medical conditions treated or associated with mTOR inhibitors:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.